Overview
Marvin Feldman is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Familial Colorectal Cancer, and Angiosarcoma.
His clinical research consists of co-authoring 4 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Skip Viragh Outpatient Cancer Center
Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
St Paul Place Specialists, Inc.
Sandy Kotiah is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Kotiah is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. Her top areas of expertise are Neuroendocrine Tumor, Paget Disease of the Breast, Anemia, Lynch Syndrome, and Bone Marrow Aspiration. Dr. Kotiah is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Elite provider by MediFind in the treatment of Pancreatic Islet Cell Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Feldman isDistinguished. Learn about Anal Cancer.
- Familial Colorectal CancerDr. Feldman isDistinguished. Learn about Familial Colorectal Cancer.
- Laryngeal CancerDr. Feldman isDistinguished. Learn about Laryngeal Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Feldman isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Feldman isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- AngiosarcomaDr. Feldman isAdvanced. Learn about Angiosarcoma.
- Bone TumorDr. Feldman isAdvanced. Learn about Bone Tumor.
- Breast CancerDr. Feldman isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Feldman isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Experienced
- Acute Mountain SicknessDr. Feldman isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Feldman isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Feldman isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anaplastic Thyroid CancerDr. Feldman isExperienced. Learn about Anaplastic Thyroid Cancer.
- AnemiaDr. Feldman isExperienced. Learn about Anemia.
- Appendix CancerDr. Feldman isExperienced. Learn about Appendix Cancer.

